Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
Fiat Chrysler and France's Renault could soon partner up to take on the sweeping changes to the global auto industry, according to a report in the Financial Times. The...Autosread more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
In a brief exchange between Meadows and House Oversight Committee Chairman Elijah Cummings, D-Md., at a hearing Tuesday, the North Carolina Republican said Trump wanted Cummings to know Trump's "serious about working in a bipartisan way to lower prescription drug prices."
"I have a personal note that I wanted to convey to you from the president of the United States," Meadows said at the House Oversight Committee hearing on drug prices. "He wanted me to make sure that you knew that on this particular subject, not only is he serious, he's serious about working in a bipartisan way to lower prescription drug prices and when I spoke to him last night he wanted to make sure I conveyed that to you."
Cummings responded by saying, "We are willing, able and ready to work with them to get them done and thank you."
Meadows, chair of the conservative House Freedom Caucus, was on an initial list of four people Trump was considering to replace former White House Chief of Staff John Kelly, according to the Associated Press.
The committee held a hearing Tuesday on why prescription drug prices are high in the U.S. Most lawmakers across the aisle agree drug prices are too high, but both parties have differed on their approach.
Cummings earlier this month said he sent letters to 12 drugmakers seeking detailed information and documents about the companies' pricing practices. Cummings, along with Sen. Bernie Sanders and Rep. Ro Khanna, D-Ca., also introduced legislation aimed at lowering drug costs.
The legislation would permit the Department Health and Human Services to negotiate lower prices for drugs under Medicare Part D, the federal health program that helps beneficiaries pay for self-administered medicines. It would also allow Americans to import lower priced drugs from abroad and peg the price of prescription drugs in the U.S. to the median price in five major countries — Canada, the United Kingdom, France, Germany and Japan.
Trump's administration has also vowed to lower drug costs. The administration has several proposals that would offer lower out-of-pocket costs for American consumers, which include changes to Medicare Part D and Part B. Medicare is the government insurer for the elderly and disabled.
Democrats, who regained control of the House this month, listed lowering prescription drug costs as one of their top priorities. Spending on prescription drugs in the U.S. increased to $333.4 billion in 2017, according to the latest data from the Centers for Medicare and Medicaid Services. Democrats have placed their focus on the pharmaceutical industry, which sells drugs at higher prices in the U.S. than abroad.
Pharmaceutical companies say price increases have been modest and argue lowering drug profits would could hinder the industry in making investments towards new and innovative cures.